Hjem › Akut myelogen leukemi
Kliniske studier for Akut myelogen leukemi rekrutterer i USA
276 studier for Akut myelogen leukemi rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
- Miami, FL24 studier
- Washington, DC24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Dallas, TX21 studier
- Nashville, TN21 studier
- Birmingham, AL21 studier
- Queens, NY21 studier
- Cincinnati, OH20 studier
- Cleveland, OH20 studier
- Edison, NJ20 studier
- Minneapolis, MN20 studier
- Buffalo, NY19 studier
- Mountain View, CA19 studier
- Baltimore, MD19 studier
- Pittsburgh, PA18 studier
- Winston-Salem, NC18 studier
- Greenburgh, NY18 studier
- Salt Lake City, UT17 studier
- Ann Arbor, MI17 studier
- New Haven, CT17 studier
- Milwaukee, WI17 studier
- Rochester, NY16 studier
- Charlotte, NC16 studier
- Aurora, CO16 studier
- Cedar Rapids, IA16 studier
- Charlottesville, VA16 studier
- Madison, WI16 studier
Etter delstat
- Alabama21 studier
- Arizona22 studier
- Arkansas13 studier
- California79 studier
- Colorado22 studier
- Connecticut17 studier
- Delaware7 studier
- District of Columbia10 studier
- Florida55 studier
- Georgia38 studier
- Hawaii7 studier
- Idaho9 studier
- Illinois31 studier
- Indiana14 studier
- Iowa17 studier
- Kansas20 studier
- Kentucky14 studier
- Louisiana13 studier
- Maine9 studier
- Maryland31 studier
- Massachusetts45 studier
- Michigan24 studier
- Minnesota27 studier
- Mississippi8 studier
- Missouri23 studier
- Montana6 studier
- Nebraska10 studier
- Nevada9 studier
- New Hampshire9 studier
- New Jersey32 studier
- New Mexico9 studier
- New York71 studier
- North Carolina43 studier
- North Dakota4 studier
- Ohio57 studier
- Oklahoma14 studier
- Oregon27 studier
- Pennsylvania45 studier
- Rhode Island11 studier
- South Carolina16 studier
- South Dakota6 studier
- Tennessee31 studier
- Texas94 studier
- Utah17 studier
- Vermont7 studier
- Virginia24 studier
- Washington41 studier
- West Virginia6 studier
- Wisconsin25 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07581002Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
RekruttererFase 2
Alder 60 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07437950Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07304011Assessment of Geriatric Evaluations Impact on New AML Guidance
RekruttererObservasjonsstudie
Alder 50 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05909501Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06904066Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07723703Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06484062Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
Alder 0 til 38 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06131801A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
Alder 12 til 78 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruttererFase 2
Alder 18 til 59 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05564390Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07211958Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT03874052Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT03661307Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06871410A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 12 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05360160A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
RekruttererFase 1
Opp til 21 år · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07012044Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06317649A Study of CRD3874-SI in People With Leukemia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07661095Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.